Prevalence and Clinical Profile of Pancreatic Cancer-Associated Diabetes Mellitus

Gastroenterology

Volumn 134, Issue 4, 2008, Pages 981-987

  Pannala, Rahul ^a   Leirness, Jeffery B ^b   Bamlet, William R ^b   Basu, Ananda ^b   Petersen, Gloria M ^b   Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREATICODUODENECTOMY; PREVALENCE; PRIORITY JOURNAL;

EID: 41349090088     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.01.039     Document Type: Article

References (36)

1. Jemal A., Seigel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Wang F., Herrington M., Larsson J., et al. The relationship between diabetes and pancreatic cancer. Mol Cancer 2 (2003) 4
3. Huxley R., Ansary-Moghaddam A., Berrington de Gonzalez A., et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92 (2005) 2076-2083
4. Chari S., Leibson C.L., de Andrade M., et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129 (2005) 504-511
5. Gupta S., Vittinghoff E., Bertenthal D., et al. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol 4 (2006) 1366-1372
6. Wang F., Gupta S., and Holly E.A. Diabetes mellitus and pancreatic cancer in a population-based case control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev 15 (2006) 1458-1463
7. Noy A., and Bilezikian J.P. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab 79 (1994) 1223-1231
8. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation (2006), World Health Organization, Geneva, Switzerland
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (2007) S42-S47
10. Chari S.T., Klee G.G., Miller L.J., et al. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 121 (2001) 640-645
11. Chari S.T., Leibson C.L., Rabe K.G., et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134 (2007) 95-101
12. Gullo L., Pezzilli R., and Morselli-Labate A.M. Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group. N Engl J Med 331 (1994) 81-84
13. Permert J., Ihse I., Jorfeldt L., et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80 (1993) 1047-1050
14. Fogar P., Pasquali C., Basso D., et al. Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 14 (1994) 2827-2830
15. Seiler C.A., Wagner M., Bachmann T., et al. Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection-long term results. Br J Surg 92 (2005) 547-556
16. American Joint Committee on Cancer. Exocrine pancreas. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York, NY 157-164
17. Cersosimo E., Pisters P.W., Pesola G., et al. Insulin secretion and action in patients with pancreatic cancer. Cancer 67 (1991) 486-493
18. Permert J., Ihse I., Jorfeldt L., et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159 (1993) 101-107
19. Cuzick J., and Babiker A.G. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer 43 (1989) 415-421
20. Hiatt R.A., Klatsky A.L., and Armstrong M.A. Pancreatic cancer, blood glucose and beverage consumption. Int J Cancer 41 (1988) 794-797
21. Bell E. Carcinoma of the pancreas. I. A clinical and pathologic study of 609 necropsied cases. II. The relation of carcinoma of the pancreas to diabetes mellitus. Am J Pathol 33 (1957) 499-523
22. Green R.C., Baggenross A.H., and Sprague R.G. Diabetes mellitus in association with primary carcinoma of the pancreas. Diabetes 7 (1958) 308-311
23. Must A., Spadano J., Coakley E.H., et al. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
24. Legro R.S., Kunselman A.R., Dodson W.C., et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84 (1999) 165-169
25. Coustan D.R., Nelson C., Carpenter M.W., et al. Maternal age and screening for gestational diabetes: a population-based study. Obstet Gynecol 73 (1989) 557-561
26. Permert J., Larsson J., Westermark G.T., et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 330 (1994) 313-318
27. Permert J., Larsson J., Fruin A.B., et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 15 (1997) 60-68
28. Nakamura T., Imamura K., Takebe K., et al. Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis. Int J Pancreatol 20 (1996) 169-175
29. Bank S., Marks I.N., and Vinik A.I. Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol 64 (1975) 13-22
30. Basso D., Brigato L., Veronesi A., et al. The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res 15 (1995) 2585-2588
31. Basso D., Valerio A., Brigato L., et al. An unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes. Pancreas 15 (1997) 132-138
32. Basso D., Millino C., Greco E., et al. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes. Gut 53 (2004) 1159-1166
33. Li J., and Adrian T.E. A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myoblasts. Biochem Biophys Res Commun 260 (1999) 626-633
34. Wang F., Larsson J., Abdiu A., et al. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol 21 (1997) 157-164
35. Wang F., Larsson J., Adrian T.E., et al. In vitro influences between pancreatic adenocarcinoma cells and pancreatic islets. J Surg Res 79 (1998) 13-19
36. Basso D., Valerio A., Seraglia R., et al. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide. Pancreas 24 (2002) 8-14